Back to Agendas
Session 8: Workshop D - Innovative Pathways for Expedited Regulatory Approvals; Room C01
Session Chair(s)
Vincent I. Ahonkhai, MD, FAAFP
Senior Advisor, Global Health
Bill & Melinda Gates Foundation, United States
Rasmane Semde
General Director
Direction de la Pharmacie et du Medicament, Burkina Faso
Chair and Moderator: Vincent I. Ahonkhai
Rapporteur: Rasmane Semde
This session will give an overview of new / expedite regulatory pathways for medicines and vaccines, as well as analyse lessons learnt from existing innovative /pilot pathways: what could be replicated and what should be avoided. Opportunities and recommendations will be discussed.
Speaker(s)
New / expedited regulatory pathways - AMRH
Samvel Azatyan, MD, PhD
World Health Organization (WHO), Switzerland
Team Lead, Regulatory Convergence and Networks (RCN/REG)
Experience with WHO Collaborative Registration Procedure
Milan Smid, MD, PhD
World Health Organization (WHO), Switzerland
Department of Essential Medicines and Health Products (EMP)
Innovative Pathways to Expedited Regulatory Approvals: ZAZIBONA Collaboration
Luther Gwaza, PhD
World Health Organization (WHO), Switzerland
Technical Officer
Fabienne Y. Benoist, PhD, MPH
DNDi, Switzerland
Head of Regulatory Affairs
Have an account?
Ways to register
Registration fee includes conference delegate material, refreshments and lunches.
Registration fee can be settled via bank transfer or by Visa and MasterCard credit cards.